Drug Profile
Research programme: targeted cancer therapies - Spirogen
Alternative Names: Project P061; Project P062Latest Information Update: 10 Aug 2021
Price :
$50
*
At a glance
- Originator Spirogen
- Class Benzodiazepines; Drug conjugates; Pyrroles
- Mechanism of Action DNA cross linking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 15 Oct 2013 Spirogen has been acquired by MedImmune
- 15 Oct 2013 No development reported for Cancer in United Kingdom (unspecified route)
- 09 Feb 2011 Early research is ongoing in United Kingdom